Detalhe da pesquisa
1.
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
Int J Cancer
; 145(7): 1798-1808, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680712
2.
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint.
Eur Urol
; 75(6): 929-937, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528222
3.
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial.
Haematologica
; 93(6): 817-25, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18469351
4.
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
Neuro Oncol
; 20(2): 259-267, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036345
5.
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.
Neuro Oncol
; 20(2): 249-258, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29016998
6.
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
Neuro Oncol
; 20(10): 1411-1418, 2018 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660005
7.
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib.
J Clin Pharmacol
; 56(9): 1130-40, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865195
8.
Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK.
J Clin Pharmacol
; 55(9): 1012-23, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854986
9.
Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.
J Clin Pharmacol
; 55(11): 1293-302, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907407
10.
A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer.
Thyroid
; 24(10): 1508-14, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25102375
11.
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
Br J Haematol
; 136(3): 501-8, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17233848